ZVRA vs. PODD
ZVRA (Zevra Therapeutics Inc.) and PODD (Insulet Corporation) are both stocks. Both are in the Healthcare sector — ZVRA in Biotechnology, PODD in Medical Devices. Over the past 10 years, ZVRA returned -16.40%/yr vs 17.35%/yr for PODD. At a 0.18 correlation, their price movements are largely independent.
Performance
ZVRA vs. PODD - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ZVRA achieves a 41.18% return, which is significantly higher than PODD's -47.33% return. Over the past 10 years, ZVRA has underperformed PODD with an annualized return of -16.40%, while PODD has yielded a comparatively higher 17.35% annualized return.
ZVRA
- 1D
- -2.47%
- 1M
- 13.76%
- YTD
- 41.18%
- 6M
- 51.86%
- 1Y
- 35.01%
- 3Y*
- 29.54%
- 5Y*
- -2.85%
- 10Y*
- -16.40%
PODD
- 1D
- 0.34%
- 1M
- 0.58%
- YTD
- -47.33%
- 6M
- -49.37%
- 1Y
- -50.69%
- 3Y*
- -18.98%
- 5Y*
- -11.92%
- 10Y*
- 17.35%
ZVRA vs. PODD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ZVRA Zevra Therapeutics Inc. | 41.18% | 7.43% | 27.33% | 42.70% | -47.30% | -22.23% | 84.70% | -78.71% | -56.05% | 37.29% |
PODD Insulet Corporation | -47.33% | 8.88% | 20.32% | -26.30% | 10.64% | 4.08% | 49.32% | 115.83% | 14.96% | 83.12% |
Correlation
The correlation between ZVRA and PODD is 0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.05 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.14 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.24 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.17 |
Correlation (All Time) Calculated using the full available price history since Apr 16, 2015 | 0.18 |
The correlation between ZVRA and PODD shifts across timeframes, from 0.05 (1 year) to 0.24 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
ZVRA:
$761.92M
PODD:
$10.51B
ZVRA:
$2.16
PODD:
$4.29
ZVRA:
5.85
PODD:
34.88
ZVRA:
5.94
PODD:
3.64
ZVRA:
3.70
PODD:
8.07
ZVRA:
$122.29M
PODD:
$2.90B
ZVRA:
$104.94M
PODD:
$2.06B
ZVRA:
$149.15M
PODD:
$529.70M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ZVRA vs. PODD — Risk / Return Rank
ZVRA
PODD
ZVRA vs. PODD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Zevra Therapeutics Inc. (ZVRA) and Insulet Corporation (PODD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ZVRA | PODD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.89 | ||
| Sortino ratioReturn per unit of downside risk | +3.35 | ||
| Omega ratioGain probability vs. loss probability | 1.16 | 0.74 | +0.42 |
| Calmar ratioReturn relative to maximum drawdown | 0.81 | -0.85 | +1.66 |
| Martin ratioReturn relative to average drawdown | 1.41 | -1.78 | +3.20 |
Loading charts...
Drawdowns
ZVRA vs. PODD - Drawdown Comparison
The maximum ZVRA drawdown since its inception was -99.27%, which is greater than PODD's maximum drawdown of -90.28%. Use the drawdown chart below to compare losses from any high point for ZVRA and PODD.
Loading charts...
Drawdown Indicators
| ZVRA | PODD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.27% | -90.28% | -8.99% |
Max Drawdown (1Y)Largest decline over 1 year | -43.47% | -59.63% | +16.16% |
Max Drawdown (3Y)Largest decline over 3 years | -43.47% | -59.63% | +16.16% |
Max Drawdown (5Y)Largest decline over 5 years | -74.01% | -61.31% | -12.70% |
Max Drawdown (10Y)Largest decline over 10 years | -97.85% | -61.31% | -36.54% |
Current DrawdownCurrent decline from peak | -96.65% | -57.57% | -39.08% |
Average DrawdownAverage peak-to-trough decline | -86.41% | -24.99% | -61.42% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 24.87% | 28.42% | -3.55% |
Volatility
ZVRA vs. PODD - Volatility Comparison
Zevra Therapeutics Inc. (ZVRA) has a higher volatility of 24.56% compared to Insulet Corporation (PODD) at 13.00%. This indicates that ZVRA's price experiences larger fluctuations and is considered to be riskier than PODD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ZVRA | PODD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 24.56% | 13.00% | +11.56% |
Volatility (6M)Calculated over the trailing 6-month period | 40.23% | 30.47% | +9.76% |
Volatility (1Y)Calculated over the trailing 1-year period | 62.90% | 38.15% | +24.75% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 60.49% | 42.74% | +17.75% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 81.46% | 42.54% | +38.92% |
Dividends
ZVRA vs. PODD - Dividend Comparison
Neither ZVRA nor PODD has paid dividends to shareholders.
Financials
ZVRA vs. PODD - Financials Comparison
This section allows you to compare key financial metrics between Zevra Therapeutics Inc. and Insulet Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ZVRA and PODD have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ZVRA has higher volatility (24.56%) compared to PODD (13.00%). In terms of maximum drawdown, ZVRA dropped -99.27% vs PODD's -90.28%.
ZVRA currently has the higher Sharpe Ratio (0.56 vs -1.33), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ZVRA and PODD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer